Vogel Marc, Bucher Patricia, Strasser Johannes, Liechti Matthias E, Krähenbühl Stephan, Dürsteler Kenneth M
a Senior Physician, Division of Substance Use Disorders , Psychiatric Hospital of the University of Basel , Basel , Switzerland.
b Pharmacist, Division of Clinical Pharmacology , University Hospital of Basel and University of Basel , Basel , Switzerland.
J Psychoactive Drugs. 2016 Apr-Jun;48(2):93-100. doi: 10.1080/02791072.2015.1130883. Epub 2016 Mar 3.
Methylphenidate (MPH) is commonly prescribed for attention deficit hyperactivity disorder (ADHD). Recreational nonmedical use has been described and also occurs in patients on opioid maintenance treatment (OMT). MPH has been proposed for use as replacement therapy in cocaine dependence, although evidence for efficacy is inconclusive. We conducted a cross-sectional interview study on patterns of MPH use in a sample of 20 MPH-using patients on OMT with a history of cocaine use. We assessed symptoms of depression, ADHD during childhood, and retrospective subjective-effects profiles of MPH and cocaine. Risky patterns of MPH use were common, in particular illicit acquisition, use of high doses, and parenteral administration. Sixty percent of patients reported having used MPH as a substitute for cocaine. Correspondingly, the subjective-effect profiles of MPH and cocaine showed striking parallels, with overall effects of MPH being rated more positively than those of cocaine. Proportions of patients with elevated scores for depression or childhood ADHD were large, highlighting the importance of treating dual disorders in this population. Clinical studies on MPH substitution in cocaine-dependent patients on opioid maintenance treatment could benefit from consideration of the patterns of application of MPH in this population. Results are preliminary due to small sample size.
哌甲酯(MPH)常用于治疗注意力缺陷多动障碍(ADHD)。其非医疗性的娱乐用途已被报道,且在接受阿片类药物维持治疗(OMT)的患者中也有发生。虽然MPH用于可卡因依赖替代疗法的疗效证据尚无定论,但已有相关应用提议。我们对20名有可卡因使用史且正在接受OMT的MPH使用者进行了横断面访谈研究,以了解MPH的使用模式。我们评估了抑郁症状、童年期ADHD以及MPH和可卡因的回顾性主观效应概况。MPH的危险使用模式很常见,尤其是非法获取、高剂量使用和肠胃外给药。60%的患者报告曾使用MPH替代可卡因。相应地,MPH和可卡因的主观效应概况显示出惊人的相似之处,总体而言,MPH的效应比可卡因得到更积极的评价。抑郁或童年期ADHD得分升高的患者比例很大,这凸显了治疗该人群双重障碍的重要性。关于在接受阿片类药物维持治疗的可卡因依赖患者中使用MPH替代疗法的临床研究,可从考虑该人群中MPH的应用模式中获益。由于样本量小,结果为初步结果。